A detailed history of Royal London Asset Management LTD transactions in Bio Techne Corp stock. As of the latest transaction made, Royal London Asset Management LTD holds 57,136 shares of TECH stock, worth $3.93 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
57,136
Previous 57,136 -0.0%
Holding current value
$3.93 Million
Previous $4.09 Million 11.53%
% of portfolio
0.01%
Previous 0.01%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 07, 2024

SELL
$62.12 - $84.15 $121,196 - $164,176
-1,951 Reduced 3.3%
57,136 $4.09 Million
Q1 2024

May 14, 2024

SELL
$65.98 - $77.09 $117,378 - $137,143
-1,779 Reduced 2.92%
59,087 $4.16 Million
Q4 2023

Feb 13, 2024

SELL
$52.83 - $78.22 $18,015 - $26,673
-341 Reduced 0.56%
60,866 $4.7 Million
Q2 2023

Aug 11, 2023

BUY
$73.76 - $85.98 $397,345 - $463,174
5,387 Added 9.65%
61,207 $5 Million
Q1 2023

May 15, 2023

SELL
$71.62 - $86.62 $19,981 - $24,166
-279 Reduced 0.5%
55,820 $4.14 Million
Q4 2022

Feb 09, 2023

BUY
$80.67 - $352.29 $3.52 Million - $15.4 Million
43,606 Added 349.04%
56,099 $4.65 Million
Q1 2022

May 13, 2022

BUY
$353.85 - $487.79 $1.19 Million - $1.65 Million
3,373 Added 36.98%
12,493 $5.41 Million
Q4 2021

Oct 18, 2022

BUY
$456.15 - $525.06 $2 Million - $2.3 Million
4,375 Added 92.2%
9,120 $4.72 Million
Q4 2021

Jan 18, 2022

BUY
$456.15 - $525.06 $2 Million - $2.3 Million
4,375 Added 92.2%
9,120 $4.72 Million
Q3 2021

Oct 18, 2022

SELL
$444.87 - $538.88 $3.45 Million - $4.18 Million
-7,748 Reduced 62.02%
4,745 $2.3 Million
Q3 2021

Nov 02, 2021

BUY
$444.87 - $538.88 $2.11 Million - $2.56 Million
4,745 New
4,745 $2.3 Million

Others Institutions Holding TECH

About BIO-TECHNE Corp


  • Ticker TECH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,222,600
  • Market Cap $2.7B
  • Description
  • Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...
More about TECH
Track This Portfolio

Track Royal London Asset Management LTD Portfolio

Follow Royal London Asset Management LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal London Asset Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Royal London Asset Management LTD with notifications on news.